ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2014–2023
Source type
Journal
Open access
Yes
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics is not currently indexed in Scopus, DOAJ. Published by Cell Press.
Checked against the index lists dated .
ISSN 2372-7705Verify ISSN ↗
Publisher: Cell Press
Scopus · InactiveOpen Access
1
Indexed in
Cost to publish: Checking DOAJ for article charges…
DOAJDirectory of Open Access Journals (live)
Listed in DOAJ
Open accessFully open access, peer reviewed
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Molecular Therapy Oncolytics indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2014–2023).
What is the impact factor of Molecular Therapy Oncolytics?
Molecular Therapy Oncolytics has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Molecular Therapy Oncolytics?
The publisher lists an article processing charge of about US$3,900 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Molecular Therapy Oncolytics and what is its ISSN?
Molecular Therapy Oncolytics is published by Cell Press. Its ISSN is 2372-7705.
Is Molecular Therapy Oncolytics in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Molecular Therapy Oncolytics open access?
Yes — it is an open-access journal, listed in DOAJ.
Scopus coverage history
Scopus indexed Molecular Therapy Oncolytics for 10 years, between 2014 and 2023. Coverage ended in 2023, 3 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 820 works and 27,661 citations for the title. Its most recent paper is from 2023, in line with the end of Scopus coverage in 2023, which suggests the journal stopped publishing around then.
How well cited is Molecular Therapy Oncolytics? — open metrics via OpenAlex
Molecular Therapy Oncolytics has an h-index of 69 and a 2-year mean of 0 citations per paper (OpenAlex).
69
h-index
0
2-yr mean citations
673
i10-index
820
works indexed
27,661
total citations
Publication fee · open access list price, US$
US$3,900
Molecular Therapy Oncolytics published 93 papers in 2023; its busiest recent year was 2021 with 189. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Who publishes in Molecular Therapy Oncolytics? — latest 92 articles, 2022–2023
In its latest 92 research articles (2022–2023), authors are most often from United States (41.5%), China (19.4%) and Canada (4.7%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Are there integrity warnings for Molecular Therapy Oncolytics? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2023. 13 retracted papers are recorded (15.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2023
- Retracted papers 13 · 15.9 per 1,000 papers
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Cell Press
Cell Press has 40 other titles in our data; 39 are currently indexed in Scopus.
Related journals
8 journals
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.